• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MYC辅因子:控制多种生物学结果的分子开关

MYC cofactors: molecular switches controlling diverse biological outcomes.

作者信息

Hann Stephen R

机构信息

Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2175.

出版信息

Cold Spring Harb Perspect Med. 2014 Jun 17;4(9):a014399. doi: 10.1101/cshperspect.a014399.

DOI:10.1101/cshperspect.a014399
PMID:24939054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4143105/
Abstract

The transcription factor MYC has fundamental roles in proliferation, apoptosis, tumorigenesis, and stem cell pluripotency. Over the last 30 years extensive information has been gathered on the numerous cofactors that interact with MYC and the target genes that are regulated by MYC as a means of understanding the molecular mechanisms controlling its diverse roles. Despite significant advances and perhaps because the amount of information learned about MYC is overwhelming, there has been little consensus on the molecular functions of MYC that mediate its critical biological roles. In this perspective, the major MYC cofactors that regulate the various transcriptional activities of MYC, including canonical and noncanonical transactivation and transcriptional repression, will be reviewed and a model of how these transcriptional mechanisms control MYC-mediated proliferation, apoptosis, and tumorigenesis will be presented. The basis of the model is that a variety of cofactors form dynamic MYC transcriptional complexes that can switch the molecular and biological functions of MYC to yield a diverse range of outcomes in a cell-type- and context-dependent fashion.

摘要

转录因子MYC在细胞增殖、凋亡、肿瘤发生和干细胞多能性方面发挥着重要作用。在过去30年里,人们收集了大量关于与MYC相互作用的众多辅因子以及受MYC调控的靶基因的信息,以此来理解控制其多种作用的分子机制。尽管取得了重大进展,或许也正是因为关于MYC的信息量过于庞大,对于介导其关键生物学作用的MYC分子功能,目前几乎没有达成共识。从这个角度出发,本文将综述调控MYC各种转录活性(包括经典和非经典反式激活以及转录抑制)的主要MYC辅因子,并提出一个关于这些转录机制如何控制MYC介导的细胞增殖、凋亡和肿瘤发生的模型。该模型的基础是,多种辅因子形成动态的MYC转录复合物,这些复合物可以切换MYC的分子和生物学功能,从而以细胞类型和环境依赖的方式产生多种不同的结果。

相似文献

1
MYC cofactors: molecular switches controlling diverse biological outcomes.MYC辅因子:控制多种生物学结果的分子开关
Cold Spring Harb Perspect Med. 2014 Jun 17;4(9):a014399. doi: 10.1101/cshperspect.a014399.
2
Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity.特定领域的 c-Myc 泛素化控制 c-Myc 的转录和凋亡活性。
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):978-83. doi: 10.1073/pnas.1208334110. Epub 2012 Dec 31.
3
TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis.TIP49而非TRRAP调节c-Myc和E2F1依赖性凋亡。
Oncogene. 2002 Aug 29;21(38):5835-43. doi: 10.1038/sj.onc.1205763.
4
Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.Egr1 通过一种非典型的 ARF 依赖性转录机制介导 p53 非依赖性 c-Myc 诱导的细胞凋亡。
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):632-7. doi: 10.1073/pnas.1008848108. Epub 2010 Dec 27.
5
Transcriptional control of DNA replication licensing by Myc.Myc对DNA复制许可的转录调控。
Sci Rep. 2013 Dec 6;3:3444. doi: 10.1038/srep03444.
6
Mechanism of transcriptional activation by the Myc oncoproteins.Myc癌蛋白介导的转录激活机制。
Semin Cancer Biol. 2006 Aug;16(4):242-52. doi: 10.1016/j.semcancer.2006.08.001. Epub 2006 Aug 4.
7
Impact of c-MYC expression on proliferation, differentiation, and risk of neoplastic transformation of human mesenchymal stromal cells.c-MYC 表达对人基质细胞增殖、分化和肿瘤转化风险的影响。
Stem Cell Res Ther. 2019 Mar 5;10(1):73. doi: 10.1186/s13287-019-1187-z.
8
The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.非酶 RAS 效应物 RASSF7 抑制致癌性 c-Myc 功能。
J Biol Chem. 2018 Oct 5;293(40):15691-15705. doi: 10.1074/jbc.RA118.004452. Epub 2018 Aug 23.
9
Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.Sirt1 去乙酰化 c-Myc 并促进 c-Myc/Max 复合物的形成。
Int J Biochem Cell Biol. 2011 Nov;43(11):1573-81. doi: 10.1016/j.biocel.2011.07.006. Epub 2011 Jul 22.
10
Myc: a weapon of mass destruction.Myc:一种大规模杀伤性武器。
Cell. 2004 Apr 16;117(2):153-6. doi: 10.1016/s0092-8674(04)00336-8.

引用本文的文献

1
Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation.强制表达MYC在浆细胞分化过程中引导一种独特的转录状态。
Life Sci Alliance. 2025 Jul 28;8(10). doi: 10.26508/lsa.202402814. Print 2025 Oct.
2
TEAD-targeting small molecules induce a cofactor switch to regulate the Hippo pathway.靶向TEAD的小分子诱导辅因子转换以调节Hippo信号通路。
Proc Natl Acad Sci U S A. 2025 Jul 8;122(27):e2425984122. doi: 10.1073/pnas.2425984122. Epub 2025 Jul 3.
3
Targeted degradation of CDK9 potently disrupts the MYC-regulated network.CDK9的靶向降解有力地破坏了MYC调控的网络。
Cell Chem Biol. 2025 Apr 17;32(4):542-555.e10. doi: 10.1016/j.chembiol.2025.03.001. Epub 2025 Mar 27.
4
Oocyte transcriptomes and follicular fluid proteomics of ovine atretic follicles reveal the underlying mechanisms of oocyte degeneration.绵羊闭锁卵泡的卵母细胞转录组和卵泡液蛋白质组学揭示了卵母细胞退化的潜在机制。
BMC Genomics. 2025 Feb 1;26(1):97. doi: 10.1186/s12864-025-11291-9.
5
Identification of MYC and STAT3 for early diagnosis based on the long noncoding RNA-mRNA network and bioinformatics in colorectal cancer.基于长链非编码RNA-信使核糖核酸网络和生物信息学鉴定MYC和STAT3用于结直肠癌的早期诊断
Front Immunol. 2025 Jan 3;15:1497919. doi: 10.3389/fimmu.2024.1497919. eCollection 2024.
6
Transcriptional activation and coactivator binding by yeast Ino2 and human proto-oncoprotein c-Myc.酵母Ino2和人类原癌蛋白c-Myc的转录激活及共激活因子结合
Curr Genet. 2025 Jan 16;71(1):2. doi: 10.1007/s00294-025-01309-w.
7
Targeting MYC at the intersection between cancer metabolism and oncoimmunology.靶向癌症代谢与肿瘤免疫学交汇点的 MYC。
Front Immunol. 2024 Feb 8;15:1324045. doi: 10.3389/fimmu.2024.1324045. eCollection 2024.
8
Targeting MYC-driven lymphoma: lessons learned and future directions.靶向MYC驱动的淋巴瘤:经验教训与未来方向。
Cancer Drug Resist. 2023 Apr 12;6(2):205-222. doi: 10.20517/cdr.2022.127. eCollection 2023.
9
Identification of a novel MYC target gene set signature for predicting the prognosis of osteosarcoma patients.鉴定一种用于预测骨肉瘤患者预后的新型MYC靶基因集特征。
Front Oncol. 2023 Jun 5;13:1169430. doi: 10.3389/fonc.2023.1169430. eCollection 2023.
10
MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma.MYCN 扩增与神经母细胞瘤中 γ-分泌酶复合物和 NOTCH 信号成分编码基因的表达降低有关。
Int J Mol Sci. 2023 May 2;24(9):8141. doi: 10.3390/ijms24098141.

本文引用的文献

1
MYC and the control of apoptosis.MYC与细胞凋亡的调控
Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a014407. doi: 10.1101/cshperspect.a014407.
2
MYC association with cancer risk and a new model of MYC-mediated repression.MYC与癌症风险的关联以及MYC介导的抑制作用新模型。
Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a014316. doi: 10.1101/cshperspect.a014316.
3
MYC activation is a hallmark of cancer initiation and maintenance.MYC激活是癌症起始和维持的一个标志。
Cold Spring Harb Perspect Med. 2014 Jun 2;4(6):a014241. doi: 10.1101/cshperspect.a014241.
4
MYC degradation.MYC 降解。
Cold Spring Harb Perspect Med. 2014 Mar 1;4(3):a014365. doi: 10.1101/cshperspect.a014365.
5
Genome recognition by MYC.MYC对基因组的识别
Cold Spring Harb Perspect Med. 2014 Feb 1;4(2):a014191. doi: 10.1101/cshperspect.a014191.
6
MYC and transcription elongation.MYC 与转录延伸。
Cold Spring Harb Perspect Med. 2014 Jan 1;4(1):a020990. doi: 10.1101/cshperspect.a020990.
7
An overview of MYC and its interactome.MYC 及其互作蛋白概述。
Cold Spring Harb Perspect Med. 2014 Jan 1;4(1):a014357. doi: 10.1101/cshperspect.a014357.
8
The role of MIZ-1 in MYC-dependent tumorigenesis.MIZ-1 在 MYC 依赖性肿瘤发生中的作用。
Cold Spring Harb Perspect Med. 2013 Dec 1;3(12):a014290. doi: 10.1101/cshperspect.a014290.
9
Interplay between chromatin-modifying enzymes controls colon cancer progression through Wnt signaling.染色质修饰酶之间的相互作用通过Wnt信号通路控制结肠癌进展。
Hum Mol Genet. 2014 Apr 15;23(8):2120-31. doi: 10.1093/hmg/ddt604. Epub 2013 Nov 28.
10
Cellular MYCro economics: Balancing MYC function with MYC expression.细胞微量经济学:平衡 MYC 功能与 MYC 表达。
Cold Spring Harb Perspect Med. 2013 Nov 1;3(11):a014233. doi: 10.1101/cshperspect.a014233.